Full Length Research Paper
References
|
Atiyeh BS, Costagliola M, Hayek SN, Dibo SA (2007). Effect of silver on burn wound infection control and healing: Review of the Literature Burns 33(2):139-148. |
|
|
Bacalum M, Radu M (2015). Cationic antimicrobial peptides cytotoxicity on mammalian cells: An analysis using therapeutic index integrative concept. International Journal of Peptide Research and Therapeutics 21(1):47-55. |
|
|
Beisswenger C, Bals R (2005). Functions of antimicrobial peptides in host defense and immunity. Current protein & peptide science 6(3):255-264. |
|
|
Björn C, Mahlapuu M, Mattsby-Baltzer I, Håkansson J (2016). Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r. Peptides 81:21-28. |
|
|
Van den Bogaerdt AJ, Van Zuijlen PPM, Van Galen M, Lamme EN, Middelkoop E (2002). The suitability of cells from different tissues for use in tissue-engineered skin substitutes. Archives of Dermatological Research 294(3):135-142. |
|
|
de Breij A, Riool M, Cordfunke RA, Malanovic N, de Boer L, Koning RI, Ravensbergen E, Franken M, van der Heijde T, Boekema BK, Kwakman PHS, Kamp N, El Ghalbzouri A, Lohner K, Zaat SAJ, Drijfhout JW, Nibbering PH (2018). The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Science Translational Medicine 10(423):eaan4044. |
|
|
Chu HL, Yu HY, Yip BS, Chih YH, Liang CW, Cheng HT, Cheng JW (2013). Boosting salt resistance of short antimicrobial peptides. Antimicrobial Agents and Chemotherapy 57(8):4050-4052. |
|
|
Coolen NA, Verkerk M, Reijnen L, Vlig M, van den Bogaerdt AJ, Breetveld M, Gibbs S, Middelkoop E, Ulrich MMW (2007). Culture of keratinocytes for transplantation without the need of feeder layer cells. Cell transplantation 16(6):649-661. |
|
|
Coolen NA, Vlig M, Van Den Bogaerdt AJ, Middelkoop E, Ulrich MMW (2008). Development of an in vitro burn wound model. Wound Repair and Regeneration 14(4):559-567. |
|
|
Dijksteel GS, Ulrich MMW, Vlig M, Nibbering PH, Cordfunke RA, Drijfhout JW, Middelkoop E, Boekema BKHL (2019a). Potential factors contributing to the poor antimicrobial efficacy of SAAP-148 in a rat wound infection model. Annals of Clinical Microbiology and Antimicrobials 18(1):38. |
|
|
Dijksteel GS, Nibbering PH, Ulrich MMW, Middelkoop E, Boekema BKHL (2019b). SPS-neutralization in tissue samples for efficacy testing of antimicrobial peptides. BMC Infectious Diseases 19(1):1093. |
|
|
Dijksteel GS, Ulrich MMW, Vlig M, Sobota A, Middelkoop E, Boekema BKHL (2020). Safety and bactericidal efficacy of cold atmospheric plasma generated by a flexible surface Dielectric Barrier Discharge device against Pseudomonas aeruginosa in vitro and in vivo. Annals of Clinical Microbiology and Antimicrobials 19(1):37. |
|
|
Gentilucci L, De Marco R, Cerisoli L (2010). Chemical modifications designed to improve peptide stability: Incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Current Pharmaceutical Design 16(28):3185-3203. |
|
|
Glik J, Kawecki M, Gaździk T, Nowak M (2012). The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis. Polish Journal of Surgery 84(1):6-16. |
|
|
Gordon YJ, Romanowski EG, McDermott AM (2005). A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Current Eye Research 30(7):505-515. |
|
|
Gould PW, Villiger JW (1986). Clinical and bacteriological efficacy of mupirocin (Bactroban): a new topical antibiotic. The New Zealand Medical Journal 99(805):516. |
|
|
Haisma EM, De Breij A, Chan H, Van Dissel JT, Drijfhout JW, Hiemstra PS, El Ghalbzouri A, Nibbering PH (2014). LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents. Antimicrobial Agents and Chemotherapy 58(8):4411-4419. |
|
|
Haisma EM, Göblyös A, Ravensbergen B, Adriaans AE, Cordfunke RA, Schrumpf J, Limpens, RWAL, Schimmel KJM, den Hartigh J, Hiemstra PS, Drijfhout JW, El Ghalbzouri A, Nibbering PH (2016). Antimicrobial peptide P60.4Ac-containing creams and gel for eradication of methicillin-resistant Staphylococcus aureus from cultured skin and airway epithelial surfaces. Antimicrobial Agents and Chemotherapy 60(7):4063-4072. |
|
|
Huang H N, Pan CY, Chan YL, Chen JY, Wu CJ (2014). Use of the antimicrobial peptide pardaxin (GE33) to protect against methicillin-resistant Staphylococcus aureus infection in mice with skin injuries. Antimicrobial Agents and Chemotherapy 58(3):1538-1545. |
|
|
Jiang Z, Vasil AI, Hale JD, Hancock REW, Vasil ML, Hodges RS (2008). Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α-helical cationic antimicrobial peptides. Biopolymers - Peptide Science Section 90(3):369-383. |
|
|
Karim AS, Yan A, Ocotl E, Bennett DD, Wang Z, Kendziorski C, Gibson ALF (2019). Discordance between histologic and visual assessment of tissue viability in excised burn wound tissue. Wound Repair and Regeneration 27(2):150-161. |
|
|
Kumar P, Kizhakkedathu JN, Straus SK (2018). Antimicrobial peptides: Diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules 8(1):4. |
|
|
McCrudden MTC, McLean DTF, Zhou M, Shaw J, Linden GJ, Irwin CR, Lundy FT (2014). The host defence peptide LL-37 is susceptible to proteolytic degradation by wound fluid isolated from foot ulcers of diabetic patients. International Journal of Peptide Research and Therapeutics 20(4):457-464. |
|
|
Meikle TG, Zabara A, Waddington LJ, Separovic F, Drummond CJ, Conn CE (2017). Incorporation of antimicrobial peptides in nanostructured lipid membrane mimetic bilayer cubosomes. Colloids and Surfaces B: Biointerfaces 152:143-151. |
|
|
Moncla BJ, Pryke K, Rohan LC, Graebing PW (2011). Degradation of naturally occurring and engineered antimicrobial peptides by proteases. Advances in Bioscience and Biotechnology 2(6):404-408. |
|
|
Nell MJ, Tjabringa GS, Wafelman AR, Verrijk R, Hiemstra PS, Drijfhout JW, Grote JJ (2006). Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27(4):649-660. |
|
|
Pfalzgraff A, Brandenburg K, Weindl G (2018). Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Frontiers in Pharmacology 9:281. |
|
|
Promega Corporation USA (n.d.). CytoTox 96® Non-radioactive cytotoxicity assay instructions for use of product G1780. View [Accessed 6 June 2019]. |
|
|
Ramos R, Silva JP, Rodrigues AC, Costa R, Guardão L, Schmitt F, Soares R, Vilanova M, Domingues L, Gama M (2011). Wound healing activity of the human antimicrobial peptide LL37. Peptides 32(7):1469-1476. |
|
|
Rooijakkers SHM, van Kessel KPM, van Strijp JAG (2005). Staphylococcal innate immune evasion. Trends in Microbiology 13(12):596-601. |
|
|
Shai Y (2002). Mode of action of membrane active antimicrobial peptides. Biopolymers 66(4):236-248. |
|
|
Shin YP, Park HJ, Shin SH, Lee YS, Park S, Jo S, Lee YH, Lee IH (2010). Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases. Antimicrobial Agents and Chemotherapy 54(7):2855-2866. |
|
|
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wójcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004). Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrobial Agents and Chemotherapy 48(12):4673-4679. |
|
|
Song Y, Wu C, Zhang X, Bian W, Liu N, Yin S, Yang MF, Luo M, Tang J, Yang X (2019). A short peptide potentially promotes the healing of skin wound. Bioscience Reports 39(3):BSR20181734. |
|
|
Steinstraesser L, Koehler T, Jacobsen F, Daigeler A, Goertz O, Langer S, Kesting M, Steinau H, Eriksson E, Hirsch T (2008). Host defense peptides in wound healing. Molecular Medicine 14(7-8):528-537. |
|
|
Strömstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M (2009). Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrobial Agents and Chemotherapy 53(2):593-602. |
|
|
Svenson J, Brandsdal BO, Stensen W, Svendsen JS (2007). Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect. Journal of Medicinal Chemistry 50(14):3334-3339. |
|
|
Thwaite JE, Hibbs S, Titball RW, Atkins TP (2006). Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrobial Agents and Chemotherapy 50(7):2316-2322. |
|
|
Williamson DA, Carter GP, Howden BP (2017). Current and emerging topical antibacterials and antiseptics: Agents, action, and resistance patterns. Clinical Microbiology Reviews 30(3):827-860. |
|
|
Xie Z, Aphale NV, Kadapure TD, Wadajkar AS, Orr S, Gyawali D, Qian G, Nguyen KT, Yang J (2015). Design of antimicrobial peptides conjugated biodegradable citric acid derived hydrogels for wound healing. Journal of Biomedical Materials Research 103(12):3907-3918. |
|
|
Xu L, Shao C, Li G, Shan A, Chou S, Wang J, Ma Q, Dong Na (2020). Conversion of broad-spectrum antimicrobial peptides into species-specific antimicrobials capable of precisely targeting pathogenic bacteria. Scientific Reports 10(1):944. |
|
|
Yin LM, Edwards MA, Li J, Yip CM, Deber CM (2012). Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. Journal of Biological Chemistry 287(10):7738-7745. |
|
|
Zasloff M (2002). Antimicrobial peptides of multicellular organisms. Nature 415(6870):389-395. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
